N-Acetyl Semax Amidate: Dosage, Benefits & Side Effects
By Peptide Assistant Editorial Team · · · 12 sources cited
Overview
N-Acetyl Semax Amidate (NASA) is a modified form of Semax, a synthetic heptapeptide analog of ACTH(4-10), modified in the hope of better stability and blood-brain barrier penetration. The N-acetyl and C-terminal amide modifications are meant to slow enzymatic degradation, but the half-life and potency of the modified peptide have not been measured in any published study. It is widely regarded as one of the most effective peptide nootropics for focus, memory, and neuroprotection.
Mechanism of Action
N-Acetyl Semax Amidate works through multiple synergistic neurotrophin and neurotransmitter pathways. Its core mechanism involves upregulation of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) in the rat hippocampus, a region critical for memory formation; in the frontal cortex NGF expression fell instead. BDNF upregulation enhances long-term potentiation (LTP), the molecular basis of learning and memory, and promotes neuronal survival, dendritic branching, and synaptic plasticity. Additionally, NASA modulates dopaminergic, serotonergic, and cholinergic neurotransmission, increasing serotonin turnover in the striatum, while leaving dopamine levels unchanged on its own. The N-acetyl group improves lipophilicity for enhanced blood-brain barrier penetration, while the amide modification prevents carboxypeptidase degradation, though no published study compares its duration of action with that of native Semax. It also demonstrates neuroprotective effects against oxidative stress and excitotoxicity through upregulation of antioxidant enzyme expression.
N-Acetyl Semax Amidate Benefits: What the Research Shows
- Dolotov et al. (2006) in Brain Research found a single intranasal dose of Semax raised exon III BDNF mRNA threefold and BDNF protein 1.4-fold in the rat hippocampus
- Russian clinical trials on Semax (the parent compound) showed faster recovery of motor function and daily activities in ischemic stroke patients, the indication it is used for in Russia
- Research in Neurochemical Research showed Semax raises striatal serotonin turnover and strongly enhances amphetamine-induced dopamine release in rodents
- Preclinical studies show Semax reduces the behavioural deficits caused by the neurotoxin MPTP in rats (a Parkinson's model), which the authors attribute to its dopaminergic and neurotrophic actions
- Grivennikov et al. (2008) showed Semax raised the survival of cholinergic basal forebrain neurons in rat cell culture about 1.5 to 1.7 fold and stimulated choline acetyltransferase activity
- A genome-wide study in rats (BMC Genomics, 2014) found Semax mainly changed immune-system genes after focal ischemia, together with genes serving the vascular system
N-Acetyl Semax Amidate Dosage
- Intranasal: 200–600 mcg per nostril, 1–2 times daily
- Subcutaneous injection: 100–500 mcg once daily
- Start with 200 mcg intranasally to assess response before increasing
- Best used in the morning or early afternoon; may cause insomnia if dosed late
- Cycle: 2–4 weeks on, 1–2 weeks off to prevent tolerance
- Some users prefer 5 days on, 2 days off for sustained cognitive support
- Effects are noticeable within 15–30 minutes intranasally, making acute dosing effective for cognitive demands
Disclaimer: Dosing information is compiled from research literature and community protocols for educational purposes only. This is not medical advice. Always consult a qualified healthcare provider before starting any peptide protocol.
N-Acetyl Semax Amidate Side Effects & Safety
Known Side Effects
- Nasal irritation — dryness or mild burning sensation when administered intranasally, typically temporary
- Headache — occasionally reported, usually during the first few doses and resolves with continued use
- Insomnia — if dosed too late in the day due to increased alertness and dopaminergic stimulation
- Mild anxiety or overstimulation — some users sensitive to dopaminergic compounds may experience restlessness at higher doses
- Hair shedding — a rare but reported side effect attributed to melanocortin receptor activity of ACTH-derived peptides; typically reversible
- Appetite changes — mild appetite suppression reported by some users
Safety Profile
N-Acetyl Semax Amidate has no safety data of its own. Its parent compound Semax has been used in Russian clinical medicine since the 1990s, and published trials in stroke, cerebrovascular insufficiency and optic nerve disease, each enrolling tens to a few hundred patients, reported it as well tolerated. How many patients have received it in total is not published. The modified form (NASA) has no formal clinical trial data of its own and is only assumed to act like the parent peptide. Dependence and withdrawal have not been studied for either form. The primary caution is for individuals with anxiety disorders, as the dopaminergic stimulation may exacerbate symptoms at high doses. Drug interactions have not been studied in people, and caution with stimulants is warranted: in rats Semax sharply amplified amphetamine's effect on dopamine release and locomotion.
What to Expect
Within minutes (intranasal): Increased mental clarity and alertness within 15–30 minutes. Users describe a 'fog-lifting' effect with improved verbal fluency and focus. Days 1–3: Acute cognitive enhancement is immediately noticeable. Improved ability to sustain attention on complex tasks. Some users report enhanced color perception and sensory acuity. Weeks 1–2: Cumulative neurotrophin effects begin. Memory recall improves, learning capacity increases, and multitasking becomes easier. Mood is generally elevated with a calm, focused quality. Weeks 3–4: Peak effects. Users report the clearest cognitive improvements — faster processing speed, better working memory, enhanced creativity. After cessation, benefits taper over 1–2 weeks as BDNF levels gradually normalize.
Common Stacks
NA-Selank Amidate
Selank provides anxiolytic and GABAergic modulation that balances Semax's stimulatory dopaminergic effects, creating a focused-but-calm cognitive enhancement stack
Noopept
Noopept enhances AMPA and NMDA receptor sensitivity while NASA upregulates BDNF — complementary mechanisms for learning and memory
PE-22-28
PE-22-28 promotes neurogenesis and cognitive function through distinct pathways, adding to the neurotrophic support provided by NASA
Storage & Handling
Store lyophilized powder at -20°C for long-term storage or 2–8°C for up to 6 months. Nasal spray solutions should be refrigerated after preparation and used within 4 weeks. Reconstitute with bacteriostatic water or sterile saline for nasal use. Protect from light and heat. The N-acetyl amide modifications provide improved stability compared to unmodified Semax, but proper cold storage remains important.
Pricing & Available Variants
Prices sourced from peptides.gg marketplace. Prices may vary.
References
- Dolotov OV, Karpenko EA, Inozemtseva LS, et al. Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus. Brain Res. 2006.
- Dolotov OV, Karpenko EA, Seredenina TS, et al. Semax, an analogue of adrenocorticotropin (4-10), binds specifically and increases levels of brain-derived neurotrophic factor protein in rat basal forebrain. J Neurochem. 2006.
- Gusev EI, Martynov MY, Kostenko EV, et al. The efficacy of semax in the tretament of patients at different stages of ischemic stroke. Zh Nevrol Psikhiatr Im S S Korsakova. 2018.
- Gusev EI, Skvortsova VI, Miasoedov NF, et al. Effectiveness of semax in acute period of hemispheric ischemic stroke (a clinical and electrophysiological study). Zh Nevrol Psikhiatr Im S S Korsakova. 1997.
- Eremin KO, Kudrin VS, Saransaari P, et al. Semax, an ACTH(4-10) analogue with nootropic properties, activates dopaminergic and serotoninergic brain systems in rodents. Neurochem Res. 2005.
- Levitskaya NG, Sebentsova EA, Andreeva LA, et al. The neuroprotective effects of Semax in conditions of MPTP-induced lesions of the brain dopaminergic system. Neurosci Behav Physiol. 2004.
- Grivennikov IA, Dolotov OV, Zolotarev YA, et al. Effects of behaviorally active ACTH (4-10) analogue - Semax on rat basal forebrain cholinergic neurons. Restor Neurol Neurosci. 2008.
- Medvedeva EV, Dmitrieva VG, Povarova OV, et al. The peptide semax affects the expression of genes related to the immune and vascular systems in rat brain focal ischemia: genome-wide transcriptional analysis. BMC Genomics. 2014.
- Agapova TY, Agniullin YV, Shadrina MI, et al. Neurotrophin gene expression in rat brain under the action of Semax, an analogue of ACTH 4-10. Neurosci Lett. 2007.
- Shevchenko KV, Nagaev IIu, Alfeeva LIu, et al. Kinetics of Semax penetration into the brain and blood of rats after its intranasal administration. Bioorg Khim. 2006.
- Shevchenko KV, Nagaev IY, Andreeva LA, et al. Stability of Semax acetyl to proteolysis in various biological media. Dokl Biol Sci. 2013.
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks. U.S. Food and Drug Administration. 2026.
Related Peptides
Track N-Acetyl Semax Amidate in Your Protocol
Log your N-Acetyl Semax Amidate doses, track consistency, and monitor your protocol with Peptide Assistant — completely free.
Start Tracking Free